Selective Formation of 1,3-Oxazolidine-2-thiones on Ketohexose Templates

Abstract

Thiocyanic acid condensation on selectively protected ketohexose led to the isolation of five out of the seven possible 1,3-oxazolidine-2-thiones (OZT). The four isomeric spiro-OZT synthesized showed promising biological activity against d-fructose transport.

carbohydrates - bicyclic compounds - spiro compounds - d-fructose - 1,3-oxazolidine-2-thione

References

<A NAME="RD12204ST-1">1</A> Velazquez F. Olivo HF. Curr. Org. Chem.  2002,  6:  1 

<A NAME="RD12204ST-2A">2a</A> Evans DA. Kim AS. In Handbook of Reagents for Organic Synthesis: Reagents, Auxiliaries and Catalysts for C-C Bonds   Coates RM. Denmark SE. John Wiley and Sons; New York: 1999.  p.91-101  

<A NAME="RD12204ST-2B">2b</A> Evans DA. Bartroli J. Shih TL. J. Am. Chem. Soc.  1981,  103:  2127 

<A NAME="RD12204ST-2C">2c</A> Evans DA. Weber AE. J. Am. Chem. Soc.  1986,  108:  6757 

<A NAME="RD12204ST-3A">3a</A> Nagao Y. Yamada S. Kumagai T. Ochiai M. Fujita E. J. Chem. Soc., Chem. Commun.  1985,  1418 

<A NAME="RD12204ST-3B">3b</A> Hsiao CN. Liu L. Miller MJ. J. Org. Chem.  1987,  52:  2201 

<A NAME="RD12204ST-3C">3c</A> Kazmierczak F. Helquist P. J. Org. Chem.  1989,  54:  3988 

<A NAME="RD12204ST-3D">3d</A> Yan TH. Lee HC. Tan CW. Tetrahedron Lett.  1993,  34:  3559 

<A NAME="RD12204ST-3E">3e</A> Yan TH. Tan CW. Lee HC. Huang TY. J. Am. Chem. Soc.  1993,  115:  2613 

<A NAME="RD12204ST-3F">3f</A> Hsiao CN. Liu L. Miller MJ. J. Org. Chem.  1995,  60:  3301 

<A NAME="RD12204ST-3G">3g</A> Su DW. Wang YC. Yan TH. Tetrahedron Lett.  1999,  40:  4197 

<A NAME="RD12204ST-3H">3h</A> Crimmins MT. King BW. Tabet EA. Chaudhary K. J. Org. Chem.  2001,  66:  894 

<A NAME="RD12204ST-3I">3i</A> Guz NR. Phillips AJ. Org. Lett.  2002,  4:  2253 

<A NAME="RD12204ST-4A">4a</A> Kocienski PJ. Brown RCD. Pommier A. Procter M. Schmidt B. J. Chem. Soc., Perkin Trans. 1  1998,  9 

<A NAME="RD12204ST-4B">4b</A> Crimmins MT. King BW. Zuercher WJ. Choy AL. J. Org. Chem.  2000,  65:  8499 

<A NAME="RD12204ST-4C">4c</A> Crimmins MT. Zuercher WJ. Org. Lett.  2000,  2:  1065 

<A NAME="RD12204ST-4D">4d</A> Crimmins MT. Tabet EA. J. Org. Chem.  2001,  66:  4012 

<A NAME="RD12204ST-4E">4e</A> Chakraborty TK. Jayaprakash S. Laxman P. Tetrahedron  2001,  57:  9461 

<A NAME="RD12204ST-4F">4f</A> Crimmins MT. Katz JD. Washburn DG. Allwein SP. McAtee LF. J. Am. Chem. Soc.  2002,  124:  5661 

<A NAME="RD12204ST-5A">5a</A> Nagao Y. Yagi M. Ikedo T. Fujita E. Tetrahedron Lett.  1982,  23:  201 

<A NAME="RD12204ST-5B">5b</A> Nagao Y. Kumagai T. Yamada S. Fujita E. Inoue Y. Nagase Y. Abe T. J. Chem. Soc., Perkin Trans. 1  1985,  2361 

<A NAME="RD12204ST-5C">5c</A> Fujita E. Nagao Y. Adv. Heterocycl. Chem.  1989,  45:  1 

<A NAME="RD12204ST-5D">5d</A> Gueyrard D. Grumel V. Leoni O. Palmieri S. Rollin P. Heterocycles  2000,  52:  827 

<A NAME="RD12204ST-6">6</A> Leoni O. Bernardi R. Gueyrard D. Rollin P. Palmieri S. Tetrahedron: Asymmetry  1999,  10:  4775 

<A NAME="RD12204ST-7A">7a</A> Zemplen G. Gerecs A. Rados M. Ber.  1936,  39:  748 

<A NAME="RD12204ST-7B">7b</A> Bromund WH. Herbst RM. J. Org. Chem.  1945,  10:  267 

<A NAME="RD12204ST-7C">7c</A> Garcia Fernandez JM. Ortiz Mellet C. Sulfur Reports  1996,  19:  61 

<A NAME="RD12204ST-7D">7d</A> Diaz Perez VM. Garcia Moreno MI. OrtizMellet C. Fuentes J. Diaz Arribas JC. Canada FJ. Garcia Fernandez JM. J. Org. Chem.  2000,  65:  136 

<A NAME="RD12204ST-7E">7e</A> Garcia Fernandez JM. Ortiz Mellet C. Adv. Carbohydr. Chem. Biochem.  2000,  55:  35 

<A NAME="RD12204ST-8A">8a</A> Benito JM. Gomez-Garcia M. Jimenez Blanco JL. Ortiz Mellet C. Garcia Fernandez JM. J. Org. Chem.  2001,  66:  1366 

<A NAME="RD12204ST-8B">8b</A> Garcia-Moreno MI. Diaz-Perez P. Ortiz Mellet C. Garcia Fernandez JM. J. Org. Chem.  2003,  68:  8890 

<A NAME="RD12204ST-9A">9a</A> Gosselin G. Bergogne M.-C. de Rudder J. De Clerq E. Imbach J.-L. J. Med. Chem.  1986,  29:  203 

<A NAME="RD12204ST-9B">9b</A> Gosselin G. Bergogne M.-C. Imbach J.-L. Nucleosides Nucleotides  1990,  9:  81 

<A NAME="RD12204ST-9C">9c</A> Girniene J. Gueyrard D. Tatibouët A. Sackus A. Rollin P. Tetrahedron Lett.  2001,  42:  2977 

<A NAME="RD12204ST-9D">9d</A> Girniene J. Tatibouët A. Sackus A. Yang J. Holman GD. Rollin P. Carbohydr. Res.  2003,  338:  711 

<A NAME="RD12204ST-9E">9e</A> Girniene J. Tatibouët A. Sackus A. Yang J. Holman GD. Rollin P. Tetrahedron  2004,  60:  2609 

<A NAME="RD12204ST-10A">10a</A> Grouiller A. Mackenzie G. Najib B. Shaw G. Ewig D. Chem. Commun.  1998,  671 

<A NAME="RD12204ST-10B">10b</A> Lichtenthaler FW. Klotz J. Flath F.-J. Liebigs Ann. Chem.  1995,  2069 

<A NAME="RD12204ST-11">11</A> Tatibouët A. Lefoix M. Nadolny J. Martin OR. Rollin P. Yang J. Holman GD. Carbohydr. Res.  2001,  333:  327 

<A NAME="RD12204ST-12">12</A>

General Protocol for the Formation of 23 and 24: 1,2-O-Isopropylidene-3,4-di-O-benzyl-β-d-fructopyranose 20 (1.1 g, 2.75 mmol) was dissolved in a cooled solution of TFA-H₂O (3:2) and stirred at r.t. overnight. The crude solution was evaporated and co-evaporated with toluene (3 times); the residue was suspended in H₂O containing KSCN (670 mg, 6.87 mmol) and 37% HCl (0.57 mL) was added. The resulting solution was heated for 3 d at 50 °C, then cooled and extracted with EtOAc (3 times). The organic phases were collected and washed with NaHCO₃ until neutral, then with brine and dried over MgSO₄. The residue obtained after evaporation was purified on column chromatography using petroleum ether-EtOAc (1:1 mixture). Spiro-furano OZT 22 (410 mg, 1.02 mmol, 37% yield) was isolated as the first fraction then spiro-pyrano OZT 21 (250 mg, 0.62 mmol, 22% yield). Each fraction was acetylated (Ac₂O 2 mL, pyridine 5 mL, 24 h); after co-evaporation with toluene, the residue was purified on column chromatography using petroleum ether-EtOAc mixtures (8:2 for furano OZT and 7:3 for pyrano OZT). Spiro-furano OZT 23α (155 mg, 0.32 mmol, 37% yield) and then 23β (150 mg, 0.31 mmol, 35% yield) was isolated. Spiro-furano OZT 23α: [α]_D ²⁵ +134.0 (c 1.0, CHCl₃). ¹H NMR (250 MHz, CDCl₃): δ = 1.99 (s, 3 H, OAc), 2.70 (s, 3 H, NAc), 3.86 (dd, 1 H, J _3,4 = 8.0 Hz, J _4,5 = 9.1 Hz, H-4), 3.95 (dd, 1 H, J _5,6b = 4.4 Hz, J _6a,6b = 12.5 Hz, H-6b), 4.14 (d, 1 H, J _1a,1b = 10.0 Hz, H-1b), 4.22 (dd, 1 H, J _5,6a = 2.3 Hz, H-6a), 4.46 (ddd, 1 H, H-5), 4.50 (d, 1 H, J = 11.4 Hz, CH₂Ph), 4.63 (d, 1 H, J = 11.4 Hz, CH₂Ph), 4.63 (d, 1 H, J = 11.7 Hz, CH₂Ph), 4.73 (d, 1 H, J = 11.7 Hz, CH₂Ph), 4.94 (d, 1 H, H-1a), 5.09 (d, 1 H, H-3), 7.23-7.38 (m, 10 H, H-Ar). ¹³C NMR (62.5 MHz, CDCl₃): δ = 20.7 (OAc), 28.0 (NAc), 62.9 (C-6), 72.9 (CH₂Ph), 73.6 (C-1), 74.0 (CH₂Ph), 78.0 (C-5), 80.9 (C-4), 83.3 (C-3), 100.5 (C-2), 127.9, 128.2, 128.4, 128.6, 128.7, 128.9, 136.6, 137.4 (C-Ar), 170.4 (CO), 172.1 (CO), 185.7 (CS). MS (IS+): m/z = 508.0 [M + Na]⁺, 486 [M + H]⁺, 466.0 [M - Ac + Na]⁺. Anal. Calcd for C₂₅H₂₇NO₇S: C, 61.84; H, 5.61; N, 2.89. Found: C, 61.61; H, 5.59; N, 2.88. Spiro-furano OZT 23β: [α]_D ²⁵ +7.0 (c 1.2, CHCl₃). ¹H NMR (250 MHz, CDCl₃): δ = 2.07 (s, 3 H, OAc), 2.75 (s, 3 H, NAc), 4.05 (d, 1 H, J _1a,1b = 10.1 Hz, H-1b), 4.11 (ddd, 1 H, J _4,5 = 7.5 Hz, J _5,6a = 3.4 Hz, J _5,6b = 7.6 Hz, H-5), 4.20 (d, 1 H, J _3,4 = 6.5 Hz, H-3), 4.31 (dd, 1 H, J _6a,6b = 11.8 Hz, H-6b), 4.41 (d, 1 H, H-1a), 4.43 (dd, 1 H, H-6a), 4.53 (dd, 1 H, H-4), 4.55 (d, 1 H, J = 11.7 Hz, CH₂Ph), 4.60 (d, 1 H, J = 11.4 Hz, CH₂Ph), 4.66 (d, 1 H, J = 11.4 Hz, CH₂Ph), 4.68 (d, 1 H, J = 11.7 Hz, CH₂Ph), 7.21-7.40 (m, 10 H, H-Ar). ¹³C NMR (62.5 MHz, CDCl₃): δ = 21.0 (OAc), 27.6 (NAc), 65.1 (C-6), 73.2 (CH₂Ph), 73.6 (CH₂Ph), 77.6 (C-1), 80.9 (C-5), 84.2 (C-4), 87.1 (C-3), 99.5 (C-2), 127.8, 128.2, 128.3, 128.7, 128.9, 136.6, 137.5 (C-Ar), 171.0 (CO), 172.7 (CO), 186.4 (CS). MS (IS+): m/z = 508.0 [M + Na]⁺, 466.0 [M - Ac + Na]⁺. Anal. Calcd for C₂₅H₂₇NO₇S: C, 61.84; H, 5.61; N, 2.89. Found: C, 61.48; H, 5.81; N, 2.63.
Spiro-pyrano OZT 24β (50 mg, 0.10 mmol, 27% yield) and then 24α (75 mg, 0.15 mmol, 41% yield) were also isolated. Spiro-pyrano OZT 24β: [α]_D ²⁵ -98 (c 1.0, CHCl₃). ¹H NMR (250 MHz, CDCl₃): δ = 2.12 (OAc), 2.68 (NAc), 3.76 (d, 1 H, J _3,4 = 8.8 Hz, H-3), 3.90 (dd, 1 H, J _5,6b = 2.6 Hz, J _6a,6b = 12.7 Hz, H-6b), 4.06 (d, 1 H, J _1a,1b = 9.6 Hz, H-1b), 4.38 (d, 1 H, H-1a), 4.41 (dd, 1 H, J _5,6a = 1.3 Hz, H-6a), 4.42 (dd, 1 H, J _4,5 = 3.9 Hz, H-4), 4.49 (d, 1 H, J = 10.6 Hz, CH₂Ph), 4.60 (d, 1 H, J = 11.4 Hz, CH₂Ph), 4.69 (d, 1 H, J = 10.6 Hz, CH₂Ph), 4.92 (d, 1 H, J = 10.6 Hz, CH₂Ph), 5.51 (m, 1 H, H-5), 7.16-7.37 (m, 10 H, H-Ar). ¹³C NMR (62.5 MHz, CDCl₃): δ = 21.2 (OAc), 28.0 (NAc), 66.1 (C-6), 67.3 (C-5), 71.8 (CH₂Ph), 75.6 (C-3), 77.1 (C-4), 78.5 (C-1), 97.7 (C-2), 127.8, 128.1, 128.3, 128.6, 128.7, 137.3, 137.5 (C-Ar), 170.4 (CO), 174.7 (CO), 187.9 (CS). MS (IS+): m/z = 508.0 [M + Na]⁺, 466.0 [M - Ac + Na]⁺, 444.0 [M - Ac + H]⁺. Anal. Calcd for C₂₅H₂₇NO₇S: C, 61.84; H, 5.61; N, 2.89. Found: C, 61.68; H, 5.48; N, 2.85. Spiro-pyrano OZT 24α: [α]_D ²⁵ +45.0 (c 1.2, CHCl₃). ¹H NMR (250 MHz, CDCl₃): δ = 2.23 (s, 3 H, OAc), 2.65 (s, 3 H, NAc), 3.45 (dd, 1 H, J _4,3 = 10.2 Hz, J _4,5 = 2.1 Hz, H-4), 3.57 (dd, 1 H, J _5,6b = 1.3 Hz, J _6a,6b = 14.0 Hz, H-6b), 4.04 (dd, 1 H, J _5,6a = 1.3 Hz, H-6a), 4.38 (d, 1 H, J _1a,1b = 9.3 Hz, H-1b), 4.54 (d, 1 H, J = 11.4 Hz, CH₂Ph), 4.59 (d, 1 H, J = 11.4 Hz, CH₂Ph), 4.73 (d, 1 H, J = 11.4 Hz, CH₂Ph), 4.76 (d, 1 H, H-1a), 4.85 (d, 1 H, J = 11.4 Hz, CH₂Ph), 5.06 (d, 1 H, H-3), 5.34 (m, 1 H, H-5), 7.21-7.33 (m, 10 H, H-Ar). ¹³C NMR (62.5 MHz, CDCl₃): δ = 21.2 (OAc), 28.1 (NAc), 64.0 (C-6), 66.9 (C-5), 70.6 (C-1), 72.0 (CH₂Ph), 73.6 (C-3), 75.7 (CH₂Ph), 78.2 (C-4), 97.3 (C-2), 127.9, 128.1, 128.2, 128.6, 137.3, 137.6 (C-Ar), 170.7 (CO), 172.0 (CO), 186.7 (CS). MS (IS+): m/z = 508.0 [M + Na]⁺, 466.0 [M - Ac + Na]⁺, 444.0 [M - Ac + H]⁺. Anal. Calcd for C₂₅H₂₇NO₇S: C, 61.84; H, 5.60; N, 2.88. Found: C, 61.72; H, 5.57; N, 2.88.